Related Experiment Video For VX2 tumor
Updated: Jan 17, 2026
Development and Angiographic Use of the Rabbit VX2 Model for Liver Cancer
Published on: January 7, 2019
NAFLD accelerates arterial perfusion in rabbit VX2 liver tumors: a sonoVue-based contrast-enhanced ultrasound study
Zhi-Long Liu1,2, Qin Lu1,2, Qian Zhang1
1Department of Ultrasound Intervention, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Objective:
To investigate whether the background of non-alcoholic fatty liver disease(NAFLD) affects the microcirculation characteristics of VX2 hepatomas, analyze the influence of the fatty liver background on tumor angiogenesis and proliferative activity.
Methods:
24 rabbits were used to establish VX2 tumor models in the background of normal liver and NAFLD. Contrast-enhanced ultrasound was performed using SonoVue. The time-intensity curve(TIC) parameters were extracted and the expression levels of microvessel density(MVD), vascular endothelial growth factor(VEGF), Ki-67 and PCNA in tumor tissues were detected and analyzed.
Result:
The TIC parameter arrival time(AT) and rise time(RT) of VX2 liver tumors decreased under the background of NAFLD(P<0.05). There was no statistically significant difference in the tumor size, MVD, VEGF, Ki-67 and PCNA expression levels between the NAFLD group and the normal liver group(P>0.05). PI was positively correlated with MVD in both normal liver(r=0.51, P<0.05) and NAFLD(r=0.67, P<0.05) backgrounds.
Conclusion:
The background of NAFLD leads to an increase in the arterial flow velocity of VX2 tumors in the liver, but it has not significantly affected the level of angiogenesis and proliferation. The CEUS parameters can effectively reflect the level of tumor microangiogenesis and are effective tools for evaluating microvessels.
